LYRA icon

Lyra Therapeutics
LYRA

Overview Fund Trends Analyst Outlook Journalist POV

51 hedge funds and large institutions have $9.06M invested in Lyra Therapeutics in 2024 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 14 increasing their positions, 13 reducing their positions, and 42 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less ownership

Funds ownership: →

less funds holding

Funds holding: →

less first-time investments, than exits

New positions opened: | Existing positions closed:

97% less capital invested

Capital invested by funds: $283M → $9.06M (-$274M)

100% less funds holding in top 10

Funds holding in top 10: 3 → 0 (-3)

Holders
51
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$88K
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$741K
2
+$271K
3
+$207K
4
Two Sigma Advisers
Two Sigma Advisers
New York
+$149K
5
Citadel Advisors
Citadel Advisors
Florida
+$120K

Top Sellers

1
-$17.5M
2
-$17.1M
3
-$16M
4
PVI
Pura Vida Investments
New York
-$8.79M
5
ABG
Ally Bridge Group
New York
-$6.24M
Name Holding Trade Value Shares
Change 		Change in
Stake
51
–
52
–
53
–
54
–
55
–
56
–
57
–
58
–
59
–
60
–
61
–
62
–
63
–
64
–
65
–
66
–
67
–
68
–
69
–
70
–
71
–
72
–
73
–
74
–
75
–
1 2
3
4